National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

Corynebacterium granulosum P40
An insoluble fraction isolated from the bacterium Corynebacterium granulosum with potential cancer immunotherapeutic activity. As a non-specific immunostimulant, Corynebacterium granulosum P40 activates the reticulo-endothelial system; induces the production of certain cytokines; enhances macrophage activity; and potentiates a delayed-type hypersensitivity response when co-administered with an antigen. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Adjuvant P40



Previous:Cortalone, Cortef, Cortenema, Cortispray, Cortril
Next:Cosmegen, Cotrim, Coumadin, COX-2 inhibitor TG01, coxsackievirus A21

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov